PRODUCT PIPELINE

Eirgenix develops high quality biologic products, advancing an extensive pipeline of candidates to improve the lives of patients.


ProductIndicationTargetStatusMore Information
EG12014/EGI014
Trastuzumab Biosimilar
CancerHER2BLAFor more information click here
Her2 Family Products
EG1206A
Pertuzumab Biosimilar
CancerHER2Phase I 
EG13074
New Formulation
CancerHER2Preclinical 
TSY0110(EG12043)
Antibody-Drug Conjugate
CancerHER2Preclinical 
EG12021
Bevacizumab Biosimilar
CancerVEGFPreclinical 
EG74032
CRM197 Carrier Protein
-Carrier protein for conjugate vaccinesGMP manufacturing 
EG62054
Biosimilar
UndisclosedUndisclosedPreclinical